scispace - formally typeset
Journal ArticleDOI

Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4.

TLDR
This work presents a novel and scalable approach to gene expression engineering that allows for real-time annotation of gene expression changes in response to cancerigenicity and shows promise in finding novel and efficient treatments for cancer.
Abstract
1 Laboratory For Molecular Cancer Biology, Flanders Interuniversity Institute for Biotechnology (VIB), University of Ghent, Technologiepark, 927, Ghent B9052, Belgium 2 Salk Institute for Biological Studies, Gene Expression Laboratory, La Jolla, CA 92037, USA 3 Gene Expression and Diseases Unit, Institut Pasteur, Paris, France 4 The University of Texas Graduate School of Biomedical Sciences and department of Molecular Genetics, Section of Cancer Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA * Corresponding author: J-C Marine, Laboratory For Molecular Cancer Biology, VIB, Technologiepark, 927, Ghent B-9052, Belgium. Tel: þ 32-93-313-640; Fax: þ 32-93-313-516; E-mail: chris.marine@dmbr.ugent.be

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Mdm2 promotes genetic instability and transformation independent of p53.

TL;DR: It is shown that increased Mdm2 expression induced chromosome/chromatid breaks and delayed DNA double-strand break repair in cells lacking p53 but not in cells with a mutant form of Nbs1, a component of the Mre11/Rad50/Nbs1 DNA repair complex.
Journal ArticleDOI

Spotlight on the role of COP1 in tumorigenesis.

TL;DR: These findings add to the growing appreciation of the roles for E3 ligases in cancer, including the oncoproteins JUN and ETV family members, as well as the p53 tumour suppressor.
Journal ArticleDOI

Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage

TL;DR: The data indicate that binding of a 14-3-3 dimer and subsequent nuclear accumulation are essential steps toward degradation of p53's inhibitor, Hdmx, in response to DNA damage.
Journal ArticleDOI

MdmX is a substrate for the deubiquitinating enzyme USP2a

TL;DR: It is shown that MdmX is also a substrate for USP2a, and siRNA-mediated knockdown of USp2a in NTERA-2 testicular embryonal carcinoma cells and MCF7 breast cancer cells causes destabilization of Mdm X and results in a decrease in MDMX protein levels, showing that endogenous USP 2a participates in the regulation of MdnX stability.
Journal ArticleDOI

A transcription co-factor integrates cell adhesion and motility with the p53 response

TL;DR: The findings demonstrate a pathway that links the cytoskeleton with the p53 response, and suggest that the ability of JMY to regulate actin and cadherin is instrumental in coordinating cell motility with thep53 response.
References
More filters
Journal ArticleDOI

WAF1, a potential mediator of p53 tumor suppression

TL;DR: A gene is identified, named WAF1, whose induction was associated with wild-type but not mutant p53 gene expression in a human brain tumor cell line and that could be an important mediator of p53-dependent tumor growth suppression.
Journal ArticleDOI

In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

TL;DR: In this article, the authors identify potent and selective small-molecule antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts.
Journal ArticleDOI

Mdm2 promotes the rapid degradation of p53

TL;DR: It is proposed that the Mdm2-promoted degradation of p53 provides a new mechanism to ensure effective termination of the p53 signal.
Journal ArticleDOI

Regulation of p53 stability by Mdm2

TL;DR: It is shown that interaction with Mdm2 can also result in a large reduction in p53 protein levels through enhanced proteasome-dependent degradation, which may contribute to the maintenance of low p53 concentrations in normal cells.
Journal ArticleDOI

Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53

TL;DR: The data suggest that the MDM2 protein, which is induced by p53, functions as a ubiquitin ligase, E3, in human papillomavirus‐uninfected cells which do not have E6 protein.
Related Papers (5)